Table 4.

Comparison of the outcomes between three groups in 66 HIV-negative participants.

Variable	Group 1 (n = 22)	Group 2 (n = 22)	Group 3 (n = 22)	P-value
Prognosis and outcomes				0.043
Cured	7 (31.8)	14 (63.6)	14 (63.4)
Persistent or relapse infection*	13 (59.1)	2 (9.1)	5 (22.7)
Death	1 (4.5)	6 (27.3)	2 (9.1)
Lost	1 (4.5)	0	0

Data are expressed as number and percentage (%). Fisher’s exact test and Kruskal–Wallis H test were used to determine statistical significance among the groups. P < 0.05 was taken as significant.

Group 1 = patients with TM and NTM co-infections, Group 2 = patients with TM infection only, and Group 3 = patients with NTM infection only.

*Persistent or Relapse infection: In Group 1, the infection condition of patients may have been only TM persistent infection, only TM recurrent infection, only NTM persistent infection, only NTM recurrent infection, both TM persistent and recurrent infection, both NTM persistent and recurrent infection, both TM persistent infection and NTM recurrent infection, or both NTM persistent infection and TM recurrent infection. Detailed prognostic information for Group 1 can be found in Table 3 which described the treatment and patient outcomes in Group 1. In Group 2, there was one case with persistent infection and one case with relapse infection. In Group 3, there was one case with persistent infection and four cases with relapse infections.